Summary:
HistoSonics receives a $90 million contract for its tumor-fighting technology.
The Edison Histotripsy System uses a focused ultrasound to destroy liver tumors.
The technology aims to improve the quality of life for veterans suffering from liver cancer.
By the end of the year, the system will be operational in 40 hospitals.
The system offers non-invasive treatment options for patients with limited alternatives.
HistoSonics: A Game-Changer in Tumor Treatment
The Plymouth-based startup HistoSonics has made headlines with its novel ultrasound system designed to destroy and liquefy liver tumors. Recently, the company announced a significant $90 million contract with the Department of Veterans Affairs (VA) to provide quick access to its groundbreaking technology.
Innovative Technology
HistoSonics has raised over $300 million in private funding to develop its Edison Histotripsy System. This focused ultrasound system utilizes pulses to create a “bubble cloud” that collapses, effectively destroying liver tumors. According to CEO Mike Blue, this technology is the first of its kind, aiming to significantly improve the quality of life for veterans by alleviating pain and potentially extending life.
Clinical Studies and Future Plans
While the FDA has yet to evaluate the Edison System for disease treatment, the contract allows VA hospitals to participate in HistoSonics' clinical trial program. By the end of the year, the system will be operational in 40 hospitals, with plans for VA hospitals to start acquiring their own systems in 2025.
Addressing a Critical Need
Veterans experience liver cancer at a rate five times higher than the general population. The five-year contract enables VA hospitals with available funding to acquire Edison Systems immediately. Dr. Michael Kelley, from the Veterans Health Administration, stated that the histotripsy system aligns with efforts to enhance patient quality of life and reduce cancer mortality.
Non-Invasive Treatment Options
Patients suffering from liver tumors often face limited treatment options. The Edison System provides a non-invasive solution, allowing the body to process and eliminate the fluid generated during the tumor liquefaction process. Since its introduction, the technology has been utilized in over 500 procedures, with the potential to improve longevity and survival rates.
Mike Blue emphasizes the hope that this technology brings, stating, "A patient walks into a hospital every day, and after the procedure, there’s new hope that — literally within hours — they’re going to feel much better."
Comments